The United Laboratories International Holdings Statistics
Total Valuation
The United Laboratories International Holdings has a market cap or net worth of HKD 20.53 billion. The enterprise value is 16.18 billion.
Market Cap | 20.53B |
Enterprise Value | 16.18B |
Important Dates
The last earnings date was Friday, November 29, 2024.
Earnings Date | Nov 29, 2024 |
Ex-Dividend Date | Sep 19, 2024 |
Share Statistics
The United Laboratories International Holdings has 1.82 billion shares outstanding. The number of shares has decreased by -0.01% in one year.
Current Share Class | n/a |
Shares Outstanding | 1.82B |
Shares Change (YoY) | -0.01% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.95% |
Owned by Institutions (%) | 13.22% |
Float | 965.53M |
Valuation Ratios
The trailing PE ratio is 6.57 and the forward PE ratio is 6.32.
PE Ratio | 6.57 |
Forward PE | 6.32 |
PS Ratio | 1.36 |
PB Ratio | 1.41 |
P/TBV Ratio | 1.43 |
P/FCF Ratio | 12.71 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.83, with an EV/FCF ratio of 10.01.
EV / Earnings | 5.18 |
EV / Sales | 1.07 |
EV / EBITDA | 3.83 |
EV / EBIT | 4.45 |
EV / FCF | 10.01 |
Financial Position
The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.18.
Current Ratio | 2.04 |
Quick Ratio | 1.62 |
Debt / Equity | 0.18 |
Debt / EBITDA | 0.62 |
Debt / FCF | 1.63 |
Interest Coverage | 63.43 |
Financial Efficiency
Return on equity (ROE) is 23.16% and return on invested capital (ROIC) is 14.54%.
Return on Equity (ROE) | 23.16% |
Return on Assets (ROA) | 9.93% |
Return on Capital (ROIC) | 14.54% |
Revenue Per Employee | 1.00M |
Profits Per Employee | 208,328 |
Employee Count | 15,000 |
Asset Turnover | 0.66 |
Inventory Turnover | 3.30 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +66.91% in the last 52 weeks. The beta is 0.08, so The United Laboratories International Holdings's price volatility has been lower than the market average.
Beta (5Y) | 0.08 |
52-Week Price Change | +66.91% |
50-Day Moving Average | 10.72 |
200-Day Moving Average | 9.50 |
Relative Strength Index (RSI) | 55.19 |
Average Volume (20 Days) | 4,051,814 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, The United Laboratories International Holdings had revenue of HKD 15.05 billion and earned 3.12 billion in profits. Earnings per share was 1.72.
Revenue | 15.05B |
Gross Profit | 6.95B |
Operating Income | 3.63B |
Pretax Income | 3.90B |
Net Income | 3.12B |
EBITDA | 4.21B |
EBIT | 3.63B |
Earnings Per Share (EPS) | 1.72 |
Balance Sheet
The company has 7.04 billion in cash and 2.64 billion in debt, giving a net cash position of 4.40 billion or 2.42 per share.
Cash & Cash Equivalents | 7.04B |
Total Debt | 2.64B |
Net Cash | 4.40B |
Net Cash Per Share | 2.42 |
Equity (Book Value) | 14.59B |
Book Value Per Share | 8.00 |
Working Capital | 8.31B |
Cash Flow
In the last 12 months, operating cash flow was 3.32 billion and capital expenditures -1.70 billion, giving a free cash flow of 1.62 billion.
Operating Cash Flow | 3.32B |
Capital Expenditures | -1.70B |
Free Cash Flow | 1.62B |
FCF Per Share | 0.89 |
Margins
Gross margin is 46.15%, with operating and profit margins of 24.15% and 20.76%.
Gross Margin | 46.15% |
Operating Margin | 24.15% |
Pretax Margin | 25.94% |
Profit Margin | 20.76% |
EBITDA Margin | 27.98% |
EBIT Margin | 24.15% |
FCF Margin | 10.74% |
Dividends & Yields
This stock pays an annual dividend of 0.62, which amounts to a dividend yield of 5.45%.
Dividend Per Share | 0.62 |
Dividend Yield | 5.45% |
Dividend Growth (YoY) | 75.99% |
Years of Dividend Growth | 6 |
Payout Ratio | 19.99% |
Buyback Yield | 0.01% |
Shareholder Yield | 5.45% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
The United Laboratories International Holdings has an Altman Z-Score of 2.85. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.85 |
Piotroski F-Score | n/a |